This study addresses the challenges of low stability, high production costs, and inefficient peptide recovery in conventional liquid enzymatic hydrolysis of β-lactoglobulin (β-Lg) by developing a novel dopamine-modified hydrated silica-immobilized Flavourzyme (DHS-F). Our objectives were to enhance enzyme stability and reusability while improving the release of bioactive peptides. Structural characterization via FTIR and TGA confirmed the covalent binding of Flavourzyme to the carrier and revealed enhanced thermal stability. DHS-F demonstrated superior catalytic performance with 69.7 % activity at 70 °C (compared to 20.3 % for free enzyme) and broad pH adaptability (pH 6–10). It maintained over 50 % activity after 20 cycles. Hydrolysis of β-Lg by DHS-F achieved 72.6 % degree of hydrolysis, yielding over 80 % of peptides below 1 kDa. Peptidomics analysis identified 49 unique peptides with ACE inhibitory activity. This innovative method addresses the economic limitations of liquid enzymes and offers a promising avenue for efficiently producing bioactive peptides from food proteins.
β-lactoglobulin (β-LG) is a major allergen in dairy, and enzymatic hydrolysis is an effective way to reduce its antigenicity. This research aimed to explore the differential mechanisms of the effects of Alcalase and Flavourzyme from different manufacturers, Novozymes (N) and Yuanye (Y), on the antigenicity of β-LG. Following optimization using Response Surface Methodology, the antigenicity reduction rates of β-LG by the two Alcalase enzymes were both higher than those of Flavourzyme. However, the degree of hydrolysis indicated that there was no linear relationship between the DH and antigenicity. The results of conformational changes indicated that compared with the other three enzymes, N-Alcalase treatment significantly altered the vibrational stretching of C=O and N-H groups, accompanied by a reduction in α-helix content, fluorescence intensity, and surface hydrophobicity. Peptidomics analysis further revealed that N-Alcalase effectively removed critical allergenic linear epitope regions of β-LG, including amino acids (AA) 16–22, 88–107, and 150–158, where AA 88–107 tends to exhibit higher allergenic potential. In contrast, Flavourzyme exhibited limited efficacy in this regard. The findings indicate that N-Alcalase holds greater potential for reducing β-LG antigenicity, providing a theoretical foundation and technical support for the production of hypoallergenic dairy-based materials.
危险品化学品经营许可证（带存储）